Shop
Cart Details

  • Manufacturer Name : Pfizer
  • MFG # : 00069030801
  • NDC : 00069030801
  • Distributor Name : AmeriSource Bergen
PID UOM Price Qty

You are not eligible to purchase this product. Please contact your account manager for more information.

Register For Member Price

 

Product Properties:

Description Trazimera inj, 10 mg
Description S
Description S
DESI Drug Ind -; -
DESI Drug Ind -
DESI Drug Ind -; -
DESI2 Drug Ind -
Drug Category S
Drug Category USES: Trastuzumab is used to treat certain types of breast, stomach, or esophagus cancer. This medication is used to treat tumors that produce more than the normal amount of a certain substance called HER2 protein. Trastuzumab belongs to a class of medications known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. This monograph is about the following trastuzumab products: trastuzumab, trastuzumab-anns, trastuzumab-dkst, trastuzumab-dttb, trastuzumab-pkrb, trastuzumab-qyyp.
Drug Category USES: Trastuzumab is used to treat certain types of breast, stomach, or esophagus cancer. This medication is used to treat tumors that produce more than the normal amount of a certain substance called HER2 protein. Trastuzumab belongs to a class of medications known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. This monograph is about the following trastuzumab products: trastuzumab, trastuzumab-anns, trastuzumab-dkst, trastuzumab-dttb, trastuzumab-pkrb, trastuzumab-qyyp.
Drug Type Code 1
Drug Type Code COMMON BRAND NAME(S): Herceptin, Herzuma, Kanjinti, Ogivri, Trazimera
Drug Type Code COMMON BRAND NAME(S): Herceptin, Herzuma, Kanjinti, Ogivri, Trazimera
FDA Approval Date 03/11/2019
FDA Therap Equiv NR
HCPCS 1
HCPCS Q5116
HCPCS 1
Market Entry Date 03/15/2021
Medical Coverage -
Medical Coverage COVERED WITH CARRIER DISCRETION
Medical Coverage -
Termination Date -
Termination Date (trass-TOOZE-you-mob)
Termination Date (trass-TOOZE-you-mob)
Unit EA
Units Per Pkg 1
Active Ingredients 17935 trastuzumab-qyyp
Active Ingredients 17935 trastuzumab-qyyp
Active Ingredients 17935 trastuzumab-qyyp
AHFS Class 10000000 ANTINEOPLASTIC AGENTS
AHFS Class 10000000 ANTINEOPLASTIC AGENTS
AHFS Class 10000000 ANTINEOPLASTIC AGENTS
DEA Class NC
DEA Class NC
DEA Class NC
Dose Form VIAL (EA)
Dose Form VIAL (EA)
Dose Form VIAL (EA)
Fine Line Class 850085008510 All Rx Products
Fine Line Class 850085008510 All Rx Products
Fine Line Class 850085008510 All Rx Products
Gen Code and Des 81963 trastuzumab-qyyp INTRAVEN VIAL 150 MG
Gen Code and Des 81963 trastuzumab-qyyp INTRAVEN VIAL 150 MG
Gen Code and Des 81963 trastuzumab-qyyp INTRAVEN VIAL 150 MG
Inactive Ingredients 2551 polysorbates 9005645; 2598 sucrose 57501
Inactive Ingredients 2551 polysorbates 9005645; 2598 sucrose 57501
Inactive Ingredients 2551 polysorbates 9005645; 2598 sucrose 57501
OMP Family -
OMP Family -
OMP Family -
Product Category RX Pharmaceuticals
Product Category RX Pharmaceuticals
Product Category RX Pharmaceuticals
Strength 150MG
Strength 150MG
Strength 150MG
Common Brand Name COMMON BRAND NAME(S): Herceptin, Herzuma, Kanjinti, Ogivri, Trazimera
Common Brand Name Q5116
Common Brand Name Q5116
Drug Interaction -
Drug Interaction DRUG INTERACTIONS: See also Warning section. Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor's approval. Trastuzumab is very similar to trastuzumab deruxtecan, trastuzumab emtansine, and trastuzumab-hyaluronidase. Do not use a trastuzumab deruxtecan, trastuzumab emtansine, or trastuzumab-hyaluronidase product while using a trastuzumab product.
Drug Interaction -
Allocation Period -
Allocation Period -
Allocation Period -
Case Quantity 192
Case Quantity 192
Case Quantity 192
Drug Form Pack Size 1
Drug Form Pack Size 1
Drug Form Pack Size 1
Form SINGLE DOSE VIAL
Form SINGLE DOSE VIAL
Form SINGLE DOSE VIAL
Hazard Code -
Hazard Code -
Hazard Code -
Listed Chemical -
Listed Chemical -
Listed Chemical -
NIOSH Code NT1 ANTINEOPLASTIC DRUGS INCLUDING THOSE WITH MANUFACTURER'S SAFE HANDLING GUIDANCE (MSHG)
NIOSH Code NT1 ANTINEOPLASTIC DRUGS INCLUDING THOSE WITH MANUFACTURER'S SAFE HANDLING GUIDANCE (MSHG)
NIOSH Code NT1 ANTINEOPLASTIC DRUGS INCLUDING THOSE WITH MANUFACTURER'S SAFE HANDLING GUIDANCE (MSHG)
Orange Book ZB Particular pharmaceutical entity was not evaluated.
Orange Book ZB Particular pharmaceutical entity was not evaluated.
Orange Book ZB Particular pharmaceutical entity was not evaluated.
Retail Pack Quantity 1
Retail Pack Quantity 1
Retail Pack Quantity 1
Returnable Status Returnable
Returnable Status Returnable
Returnable Status Returnable
Special Storage Cond 06 Flammable Plastic
Special Storage Cond 06 Flammable Plastic
Special Storage Cond 06 Flammable Plastic
Temp Zone 30 Refrige./DoNot Freez
Temp Zone 30 Refrige./DoNot Freez
Temp Zone 30 Refrige./DoNot Freez
Unit EA
Unit EA
Unit EA
Unit Size -
Unit Size -
Unit Size -
How to Use -
How to Use -
How to Use HOW TO USE: This medication is given by slow injection into a vein by a health care professional, usually once every week or once every 3 weeks. The first injection is given over at least 90 minutes. The dosage is based on your medical condition, response to treatment, weight, and other medications you may be taking. Be sure to tell your doctor and pharmacist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products). Use this medication regularly to get the most benefit from it. To help you remember, mark the days on the calendar when you need to receive the medication. Your doctor may prescribe other medications (such as acetaminophen, diphenhydramine) for you to take before each dose to help prevent serious side effects. Follow your doctor's directions carefully.
Missed Dose 1
Missed Dose 1
Missed Dose MISSED DOSE: It is important to get each dose of this medication as scheduled. If you miss a dose, ask your doctor or pharmacist right away for a new dosing schedule.
Notes NOTES: Lab and/or medical tests (such as heart exams, complete blood count) should be done before you start using this medication and while you are using it. Keep all medical and lab appointments.
Notes EA
Notes EA
Overdose NR
Overdose NR
Overdose OVERDOSE: If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center.
Phonetic Pronunciation (trass-TOOZE-you-mob)
Phonetic Pronunciation COVERED WITH CARRIER DISCRETION
Phonetic Pronunciation COVERED WITH CARRIER DISCRETION
Precautions -
Precautions -
Precautions PRECAUTIONS: See also Warning section. Before using trastuzumab, tell your doctor or pharmacist if you are allergic to it; or to any trastuzumab, trastuzumab deruxtecan, trastuzumab emtansine, or trastuzumab-hyaluronidase products; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details. Before using this medication, tell your doctor or pharmacist your medical history, especially of: current/recent infection, heart disease, lung problems, previous cancer treatments (including radiation treatment). Trastuzumab can make you more likely to get infections or may make current infections worse. Stay away from anyone who has an infection that may easily spread (such as chickenpox, COVID-19, measles, flu). Talk to your doctor if you have been exposed to an infection or for more details. Tell your health care professional that you are using trastuzumab before having any immunizations/vaccinations. Avoid contact with people who have recently received live vaccines (such as flu vaccine inhaled through the nose). To lower the chance of getting cut, bruised, or injured, use caution with sharp objects like razors and nail cutters, and avoid activities such as contact sports. This drug may make you dizzy. Alcohol or marijuana (cannabis) can make you more dizzy. Do not drive, use machinery, or do anything that needs alertness until you can do it safely. Limit alcoholic beverages. Talk to your doctor if you are using marijuana (cannabis). Before having surgery, tell your doctor or dentist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products). Older adults may be at greater risk for heart problems (such as heart failure) while using this drug. Tell your doctor if you are pregnant or plan to become pregnant. You should not become pregnant while using trastuzumab. Trastuzumab may harm an unborn baby. Your doctor should order a pregnancy test before you start this medication. Ask about reliable forms of birth control while using this medication and for 7 months after the last dose. If you become pregnant, talk to your doctor right away about the risks and benefits of this medication. It is unknown if this drug passes into breast milk. Consult your doctor before breast-feeding while using this medication and for 7 months after stopping treatment.
Side Effects -
Side Effects -
Side Effects SIDE EFFECTS: See also Warning section. Redness/irritation at the injection site, diarrhea, muscle/joint/back pain, stomach/abdominal pain, headache, trouble sleeping, nausea, vomiting, mouth sores, and loss of appetite may occur. Nausea and vomiting can be severe. In some cases, your doctor may prescribe medication to prevent or relieve nausea and vomiting. Eating several small meals, not eating before treatment, or limiting activity may help lessen some of these effects. If any of these effects last or get worse, tell your doctor or pharmacist promptly. Remember that this medication has been prescribed because your doctor has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. Tell your doctor right away if you have any serious side effects, including: symptoms of heart failure (such as shortness of breath, swelling ankles/feet, unusual tiredness, unusual/sudden weight gain), bone pain, numbness/tingling, mental/mood changes, fast/irregular heartbeat, easy bruising/bleeding. Get medical help right away if you have any very serious side effects, including: chest pain, weakness on one side of the body, trouble speaking, vision changes, confusion. This medication may lower your ability to fight infections. This may make you more likely to get a serious (rarely fatal) infection or make any infection you have worse. Tell your doctor right away if you have any signs of infection (such as sore throat that doesn't go away, fever, chills, cough). Trastuzumab can commonly cause a rash that is usually not serious. However, you may not be able to tell it apart from a rare rash that could be a sign of a severe reaction. Tell your doctor right away if you develop any rash. A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Storage 03/11/2019
Storage 03/11/2019
Storage STORAGE: Not applicable. This medication is given in a hospital or clinic and will not be stored at home.
Uses USES: Trastuzumab is used to treat certain types of breast, stomach, or esophagus cancer. This medication is used to treat tumors that produce more than the normal amount of a certain substance called HER2 protein. Trastuzumab belongs to a class of medications known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. This monograph is about the following trastuzumab products: trastuzumab, trastuzumab-anns, trastuzumab-dkst, trastuzumab-dttb, trastuzumab-pkrb, trastuzumab-qyyp.
Uses Trazimera inj, 10 mg
Uses Trazimera inj, 10 mg

Frequently Asked Questions(FAQs)

The cost of is available for registerd members only .
is manufactured by Pfizer.
Read More

Subscribe to Our Newsletter